Claudio Guarneri (C Guarneri)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 24

Top Venues

Current oncology (Toronto, Ont.)

Dermatologic therapy

Biomedicines

Journal of clinical medicine

University of Messina

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Messina Mar 01 2006

Italy

Assistant Professor of Dermatology and Venereology :: Department of Biomedical and Dental Sciences and Morphofunctional Imaging

Publications

C Bonifati, S Lembo, A G Richetta, Marco Romanelli, F Satolli, M Corazza, Laura Atzori, C Lasagni, C Potenza, Paola Savoia, F Bardazzi, V G Di Lernia, L Bianchi, G Fabbrocini, C Giofrè, L Zichichi, Claudio Guarneri, S Pallotta, Maria-Concetta Fargnoli, F Loconsole, A Offidani, Martina Burlando, Stefano Piaserico, Ketty Peris, M Papini, C G Carrera, Antonio Costanzo, Francesca Prignano, Maria Rita Bongiorno, P Dapavo, Luca Stingeni, M Donini, G Micali, Franco Rongioletti, Giuseppe Stinco, T Gramiccia, G Cantini, Giuseppe Argenziano
Effectiveness of guselkumab in patients with facial and/or genital psoriasis: Interim analysis results at Week 12 from the GULLIVER study. Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
Luigi Gargiulo, Luciano Ibba, Piergiorgio Malagoli, Fabrizio Amoruso, Giuseppe Argenziano, Anna Balato, Federico Bardazzi, Martina Burlando, Carlo Giovanni Carrera, Giovanni Damiani, Paolo Dapavo, Valentina Dini, Chiara Franchi, Francesca Maria Gaiani, Giampiero Girolomoni, Claudio Guarneri, Claudia Lasagni, Francesco Loconsole, Angelo Valerio Marzano, Martina Maurelli, Matteo Megna, Orsini Diego, Francesca Sampogna, Massimo Travaglini, Mario Valenti, Antonio Costanzo, Alessandra Narcisi
Effectiveness, Tolerability, and Drug Survival of Risankizumab in a Real-World Setting: A Three-Year Retrospective Multicenter Study-IL PSO (ITALIAN LANDSCAPE PSORIASIS). Journal of clinical medicine 13 (2) (2024)
Luigi Gargiulo, Luciano Ibba, Piergiorgio Malagoli, Fabrizio Amoruso, Giuseppe Argenziano, Anna Balato, Federico Bardazzi, Martina Burlando, Carlo Giovanni Carrera, Giovanni Damiani, Paolo Dapavo, Valentina Dini, Chiara Franchi, Francesca Maria Gaiani, Giampiero Girolomoni, Claudio Guarneri, Claudia Lasagni, Francesco Loconsole, Angelo Valerio Marzano, Martina Maurelli, Matteo Megna, Orsini Diego, Francesca Sampogna, Massimo Travaglini, Mario Valenti, Antonio Costanzo, Alessandra Narcisi
Effectiveness, Tolerability, and Drug Survival of Risankizumab in a Real-World Setting: A Three-Year Retrospective Multicenter Study-IL PSO (ITALIAN LANDSCAPE PSORIASIS). Journal of clinical medicine 13 (2) (2024)
Ludovica Toffoli, Giulia Bazzacco, Conforti Claudio, Claudio Guarneri, Roberta Giuffrida, Enrico Zelin, Nicola di Meo, Iris Zalaudek
Pilomatrix Carcinoma: Report of Two Cases of the Head and Review of the Literature. Current oncology (Toronto, Ont.) 30 (2) (2023)
Roberta Giuffrida, Gustavo Zanin Poletto, Fabrizio Guarneri, Conforti Claudio, Claudio Guarneri, Rainer Hofmann-Wellenhof, Iris Zalaudek
Nevus count on the face for the identification of patients with higher risk of melanoma. The British journal of dermatology (2023)
Ludovica Toffoli, Giulia Bazzacco, Conforti Claudio, Claudio Guarneri, Roberta Giuffrida, Enrico Zelin, Nicola di Meo, Iris Zalaudek
Pilomatrix Carcinoma: Report of Two Cases of the Head and Review of the Literature. Current oncology (Toronto, Ont.) 30 (2) (2023)
Ludovica Toffoli, Giulia Bazzacco, Conforti Claudio, Claudio Guarneri, Roberta Giuffrida, Enrico Zelin, Nicola di Meo, Iris Zalaudek
Pilomatrix Carcinoma: Report of Two Cases of the Head and Review of the Literature. Current oncology (Toronto, Ont.) 30 (2) (2023)
Ludovica Toffoli, Giulia Bazzacco, Conforti Claudio, Claudio Guarneri, Roberta Giuffrida, Enrico Zelin, Nicola di Meo, Iris Zalaudek
Pilomatrix Carcinoma: Report of Two Cases of the Head and Review of the Literature. Current oncology (Toronto, Ont.) 30 (2) (2023)
Maria-Concetta Fargnoli, Federico Bardazzi, Luca Bianchi, Paolo Dapavo, Gabriella Fabbrocini, Paolo Gisondi, Giuseppe Micali, Anna Maria Offidani, Giovanni Pellacani, Nevena Skroza, Rosa Giuseppa Angileri, Martina Burlando, Campanati Anna, Carlo Giovanni Carrera, Andrea Chiricozzi, Andrea Conti, Clara De Simone, Vito Di Lernia, Enzo Errichetti, Marco Galluzzo, Claudio Guarneri, Claudia Lasagni, Serena Lembo, Francesco Loconsole, Matteo Megna, Maria Letizia Musumeci, Francesca Prignano, Antonio Giovanni Richetta, Emanuele Trovato, Marina Venturini, Ketty Peris, Piergiacomo Calzavara Pinton
Brodalumab for the Treatment of Moderate-to-Severe Psoriasis: An Expert Delphi Consensus Statement. Journal of clinical medicine 12 (10) (2023)
Ludovica Toffoli, Giulia Bazzacco, Conforti Claudio, Claudio Guarneri, Roberta Giuffrida, Enrico Zelin, Nicola di Meo, Iris Zalaudek
Pilomatrix Carcinoma: Report of Two Cases of the Head and Review of the Literature. Current oncology (Toronto, Ont.) 30 (2) (2023)
Ludovica Toffoli, Giulia Bazzacco, Conforti Claudio, Claudio Guarneri, Roberta Giuffrida, Enrico Zelin, Nicola di Meo, Iris Zalaudek
Pilomatrix Carcinoma: Report of Two Cases of the Head and Review of the Literature. Current oncology (Toronto, Ont.) 30 (2) (2023)
Martina Burlando, Gabriella Fabbrocini, Claudio Marasca, Paolo Dapavo, Andrea Chiricozzi, Dalma Malvaso, Valentina Dini, Campanati Anna, Annamaria Offidani, Annunziata Dattola, Raffaele Dante Caposiena Caro, Luca Bianchi, Marina Venturini, Paolo Gisondi, Claudio Guarneri, Giovanna Malara, Caterina Trifirò, Piergiorigio Malagoli, Maria-Concetta Fargnoli, Stefano Piaserico, Luca Carmisciano, Riccardo Castelli, Aurora Parodi
Adalimumab Originator vs. Biosimilar in Hidradenitis Suppurativa: A Multicentric Retrospective Study. Biomedicines 10 (10) (2022)
Laura Macca, Lucia Peterle, Manuela Ceccarelli, Ylenia Ingrasciotta, Giuseppe Nunnari, Claudio Guarneri
Vitiligo-like Lesions and COVID-19: Case Report and Review of Vaccination- and Infection-Associated Vitiligo. Vaccines 10 (10) (2022)
Angela Alibrandi, Lavinia Merlino, Claudio Guarneri, Ylenia Ingrasciotta, Agata Zirilli
Non-Motherhood between Obligation and Choice: Statistical Analysis Based on Permutation Tests of Spontaneous and Induced Abortion Rates in the Italian Context. Healthcare (Basel, Switzerland) 10 (8) (2022)
Laura Macca, Vittoria Moscatt, Manuela Ceccarelli, Ylenia Ingrasciotta, Giuseppe Nunnari, Claudio Guarneri
Hidradenitis Suppurativa in Patients with HIV: A Scoping Review. Biomedicines 10 (11) (2022)
Alfonso Motolese, Manuela Ceccarelli, Laura Macca, Federica Li Pomi, Ylenia Ingrasciotta, Giuseppe Nunnari, Claudio Guarneri
Novel Therapeutic Approaches to Psoriasis and Risk of Infectious Disease. Biomedicines 10 (2) (2022)
Federica Li Pomi, Laura Macca, Alfonso Motolese, Ylenia Ingrasciotta, Massimiliano Berretta, Claudio Guarneri
Neoplastic Implications in Patients Suffering from Hidradenitis Suppurativa under Systemic Treatments. Biomedicines 9 (11) (2021)
Paola Cutroneo, Ylenia Ingrasciotta, Valentina Isgrò, Emmanuele Venanzi Rullo, Massimiliano Berretta, Francesco Fiorica, Gianluca Trifirò, Claudio Guarneri
Psoriasis and psoriasiform reactions secondary to immune checkpoint inhibitors. Dermatologic therapy 34 (2) (2021)
Claudio Guarneri, Emmanuele Venanzi Rullo, Romina Gallizzi, Manuela Ceccarelli, Serafinella Patrizia Cannavò, Giuseppe Nunnari
Diversity of clinical appearance of cutaneous manifestations in the course of COVID-19. Journal of the European Academy of Dermatology and Venereology : JEADV 34 (9) (2020)
Manuela Ceccarelli, Emmanuele Venanzi Rullo, Massimiliano Berretta, Bruno Cacopardo, Giovanni Francesco Pellicanò, Giuseppe Nunnari, Claudio Guarneri
New generation biologics for the treatment of psoriasis and psoriatic arthritis. State of the art and considerations about the risk of infection. Dermatologic therapy 34 (1) (2020)
Alessio Facciolà, Emmanuele Venanzi Rullo, Manuela Ceccarelli, Flavia D'Andrea, Mariagiovanna Coco, Cristina Micali, Bruno Cacopardo, Andrea Marino, Serafinella P Cannavò, Michelino Di Rosa, Fabrizio Condorelli, Giovanni F Pellicanò, Claudio Guarneri, Giuseppe Nunnari
Malignant melanoma in HIV: Epidemiology, pathogenesis, and management. Dermatologic therapy 33 (1) (2019)
Valeria Papaianni, Fabrizio Guarneri, Mario Vaccaro, Francesco Borgia, Claudio Guarneri, Serafinella P Cannavò
From regulatory limitations to new opportunities: Real-life experience on the effectiveness of short courses of omalizumab in the treatment of chronic idiopatic urticaria. Dermatologic therapy 33 (1) (2019)
Serafinella P Cannavò, Valeria Papaianni, Annunziata Bartolotta, Claudio Guarneri
Secukinumab for psoriasis in a patient with familial Mediterranean fever. Dermatologic therapy 32 (6) (2019)
Irene Cacciola, Francesco Borgia, Roberto Filomia, Concetta Pitrone, Maria Stella Franzè, Angela Alibrandi, Giovanni Squadrito, Claudio Guarneri, Valeria Papaianni, Serafinella Patrizia Cannavò, Giovanni Raimondo
Outcome of cutaneous psoriasis in hepatitis C virus-infected patients treated with Direct-Acting Antiviral therapy. Journal of viral hepatitis 27 (3) (2019)

Claudio Guarneri.css-eqlu8i{font-size:small;padding-left:4px;} (C Guarneri)

Publication Activity (10 Years)

Top Topics

Top Venues

Claudio Guarneri (C Guarneri)